AMBERWIN® Pulmo

The drug AMBERWIN® Pulmo contains the active ingredient tyrosyl-D-alanyl-glycyl phenylalanyl-leucyl-arginine succinate, which belongs to the group of drugs for the treatment of diseases of the respiratory system.

The drug AMBERWIN® Pulmo is used in adults over the age of 18 for:
• treatment of community-acquired pneumonia (pneumonia that occurs outside a medical facility or in the first 48 hours after hospitalization), as part of complex therapy;
• treatment of a new coronavirus infection of moderate severity, as part of complex therapy of viral lung damage.

Overdose symptoms
In case of overdose, the risk of lowering blood pressure, dizziness, and visual disturbances increases.
Overdose Treatment
In case of overdose, you will be treated depending on the clinical manifestations.

Like all medications, AMBERWIN® Pulmo can cause undesirable reactions, but they do not occur in everyone.
Possible adverse reactions that may occur when using AMBERWIN® Pulmo:
Rarely (may occur in no more than 1 person out of 1000):
• allergic reactions
• dizziness
• visual perception disorders
• lowering blood pressure
Is unknown (based on the available data, the frequency of occurrence cannot be estimated):
• burning sensation
• taste distortion (dysgeusia)
• cough
• an increase in the level of "liver" enzymes (alanine aminotransferase (ALT), aspartate aminotransferase (AST)) is determined by the results of a blood test.

Do not use AMBERWIN® Pulmo:
• if you are allergic to tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate;
• if you are pregnant;
• If you are breastfeeding.

Tell your doctor that you are using, have recently used, or may start using any other medications.
The drug AMBERWIN® Pulmo enhances the effect of analgesic drugs. Naloxone (a drug that blocks the action of opioids) blocks the effects of AMBERWIN® Pulmo.

The holder of the registration certificate
Russian Federation
PROMOMED RUS LLC
Address: 13 Mira Avenue, building 1, office 13, Moscow, 129090
Phone: +7 (495) 640 25 28
Email: reception@promomed.pro
Manufacturer
Russian Federation
JSC "Biochemist"
Address: 15A Vasenko St., Saransk, 430030, Republic of Mordovia
Reporting of adverse reactions
Russian Federation
Federal Service for Healthcare Supervision
Address: 109012, Moscow, Slavyanskaya square, 4, building 1
Phone number: +7 800 550 99 03
Email: pharm@roszdravnadzor.gov.ru or npr@roszdravnadzor.gov.ru
Website: www.roszdravnadzor.gov.ru

Do not give the drug to children from 0 to 18 years of age, since the effectiveness and safety of using the drug in this age group has not been established.

During treatment with AMBERWIN® Pulmo, due to possible side effects (decreased blood pressure, which can lead to dizziness and impaired visual perception), be careful when performing potentially dangerous activities that require increased concentration and speed of psychomotor reactions (driving vehicles, working with moving mechanisms, dispatcher, operator)..

Keep the medicine out of the reach of children.
Do not use the drug after the expiration date (shelf life) indicated on the carton after "Good before".
The expiration date is the last day of the given month.
Store at temperatures below 25 ° C. Store in the original packaging (pack).
Do not dispose of the drug in the sewer. Ask the pharmacy employee how to dispose (destroy) drugs that are no longer needed. These measures will help protect the environment.

If you are pregnant or breastfeeding, assume that you have become pregnant, or plan to
pregnancy, consult your doctor before using the drug.
Pregnancy
Do not use AMBERWIN® Pulmo during pregnancy.
Breastfeeding
Do not use AMBERWIN® Pulmo during breast-feeding.